| Long name: |
Recombinant Loxodonta africana Neurophysin 2 (AVP) |
| Alternative names: |
E-NP, Neurophysin 2, Neurophysin-II, Neurophysin 2 |
| Gene name: |
AVP |
| Other gene names: |
AVP |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Neurophysin 2 (AVP) is a recombinant protein expressed in Yeast |
| Product category: |
Recombinant Proteins |
| Expression system: |
Yeast |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Gene target: |
Loxodonta africana Neurophysin 2 (AVP) |
| Short name: |
Loxodonta africana Neurophysin 2 (AVP) |
| Alternative name: |
Loxodonta africana Neurophysin 2 (arginine vasopressin) |
| Alternative to gene target: |
ADH and ARVP and AVP-NPII and AVRP and VP, AVP and IDBG-45432 and ENSG00000101200 and 551, AVP and IDBG-640134 and ENSBTAG00000008027 and 280728, Avp and IDBG-206576 and ENSMUSG00000037727 and 11998, Extracellular, cysteine-type endopeptidase inhibitor activity involved in apoptotic process, this GO :0002125 and maternal aggressive behavior and biological process this GO :0003084 and positive regulation of systemic arterial blood pressure and biological process this GO :0004672 and protein kinase activity and molecular function this GO :0004871 and signal transducer activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005184 and neuropeptide hormone activity and molecular function this GO :0005185 and neurohypophyseal hormone activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005829 and cytosol and cellular component this GO :0006091 and generation of precursor metabolites and energy and biological process this GO :0006468 and protein phosphorylation and biological process this GO :0006833 and water transport and biological process this GO :0007165 and signal transduction and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007621 and negative regulation of female receptivity and biological process this GO :0007625 and grooming behavior and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0014049 and positive regulation of glutamate secretion and biological process this GO :0014070 and response to organic cyclic compound and biological process this GO :0030141 and secretory granule and cellular component this GO :0030307 and positive regulation of cell growth and biological process this GO :0030425 and dendrite and cellular component this GO :0030819 and positive regulation of cAMP biosynthetic process and biological process this GO :0031394 and positive regulation of prostaglandin biosynthetic process and biological process this GO :0031894 and V1A vasopressin receptor binding and molecular function this GO :0031895 and V1B vasopressin receptor binding and molecular function this GO :0032849 and positive regulation of cellular pH reduction and biological process this GO :0033138 and positive regulation of peptidyl-serine phosphorylation and biological process this GO :0033574 and response to testosterone and biological process this GO :0035094 and response to nicotine and biological process this GO :0035176 and social behavior and biological process this GO :0035813 and regulation of renal sodium excretion and biological process this GO :0042310 and vasoconstriction and biological process this GO :0042538 and hyperosmotic salinity response and biological process this GO :0042711 and maternal behavior and biological process this GO :0043027 and cysteine-type endopeptidase inhibitor activity involved in apoptotic process and molecular function this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043084 and penile erection and biological process this GO :0043154 and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0043252 and sodium-independent organic anion transport and biological process this GO :0045087 and innate immune response and biological process this GO :0045471 and response to ethanol and biological process this GO :0045907 and positive regulation of vasoconstriction and biological process this GO :0050891 and multicellular organismal water homeostasis and biological process this GO :0051970 and negative regulation of transmission of nerve impulse and biological process this GO :0055085 and transmembrane transport and biological process this GO :0070371 and ERK1 and ERK2 cascade and biological process this GO :0070528 and protein kinase C signaling and biological process this GO :0090201 and negative regulation of release of cytochrome c from mitochondria and biological process, this GO :0004672 : protein kinase activity, this GO :0004672 : protein kinase activity and also this GO :0004871 : signal transducer activity and also this GO :0005102 : receptor binding and also this GO :0005184 : neuropeptide hormone activity and also this GO :0005185 : neurohypophyseal hormone activity and also this GO :0005515 : protein binding and also this GO :0031894 : V1A vasopressin receptor binding and also this GO :0031895 : V1B vasopressin receptor binding and also this GO :0043027 : cysteine-type endopeptidase inhibitor activity involved in apoptotic process, this GO :0004871 : signal transducer activity, this GO :0005102 : receptor binding, this GO :0005184 : neuropeptide hormone activity, this GO :0005185 : neurohypophyseal hormone activity, this GO :0005515 : protein binding, this GO :0031894 : V1A vasopressin receptor binding, this GO :0031895 : V1B vasopressin receptor binding, this GO :0043027 : cysteine-type endopeptidase inhibitor activity involved in apoptotic process, arginine vasopressin |
| Identity: |
894 |
| Gene: |
AVP |
More about : AVP |
| Long gene name: |
arginine vasopressin |
| Synonyms gene: |
ARVP |
| Synonyms: |
ADH |
| Synonyms name: |
antidiuretic hormone neurophysin II diabetes insipidus neurohypophyseal prepro-AVP-NP II prepro-arginine-vasopressin-neurophysin II copeptin |
| Locus: |
20p13 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
M25647 |
| Entrez gene record: |
551 |
| Pubmed identfication: |
1840604 |
| RefSeq identity: |
NM_000490 |
| Classification: |
Endogenous ligands |
| Havana BLAST/BLAT: |
OTTHUMG00000031733 |
| Locus Specific Databases: |
nndi LRG_715 |